5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Akathisia is a common and distressing extrapyramidal side-effect, which usually results from the use of antipsychotic medication. Previous reviews and meta-analyses have demonstrated a lack of evidence for the effectiveness of treatment strategies, which are traditionally used against neuroleptic-induced akathisia (NIA), i.e. beta-blockers, anticholinergic agents and benzodiazepines. In the last fifteen years, randomized trials have studied the effect of drugs with antiserotonergic properties on NIA. We conducted a systematic review of randomized control trials and used meta-analytic methods to quantify the overall effect size. PubMed and the Cochrane libraries were searched for eligible trials. Six randomized controlled trials were found, five of which included a placebo control group and qualified for our meta-analysis. The overall effect size in the analysis is RR = 7.10 with 95% CI 3.08-16.40 (p < 0.0001). Our findings suggest that 5-HT(2A) antagonists are effective in the treatment of NIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2021) · doi:10.1017/9781108975292 · Cited by 480
Halstead, S. M., Barnes, T. R. E., & Speller, J. C. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.177 · Cited by 108
Poyurovsky, M., Epshtein, S., Fuchs, C., Schneidman, M., Weizman, R., & Weizman, A. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084027.22282.16 · Cited by 62
Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00002 · Cited by 47
Lerner, V., Bergman, J., Statsenko, N., & Miodownik, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1118 · Cited by 44
Avital, A., Gross-Isseroff, R., Stryjer, R., Hermesh, H., Weizman, A., & Shiloh, R. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.006 · Cited by 33 · cited 1×
“apomorphine (Sachdev and Loneragan, 1993b) and zolmitriptan (Avital et al., 2009).”
Cited by
Maeda, K., Sugino, H., Akazawa, H., Amada, N., Shimada, J., Futamura, T., Yamashita, H., Ito, N., McQuade, R. D., Mørk, A., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213793 · Cited by 372
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. A. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000123 · Cited by 74
“…addition, brexpiprazole has a higher affinity at the 5-HT2A receptor than aripiprazole and as 5-HT2A antagonism may reduce D2 antagonist-induced akathisia (Laoutidis and Luckhaus, 2014), brexpiprazole may have the potential to be associated with fewer EPS-related events compared with aripiprazole.”
Result
Metadata
- Authors
- Laoutidis, Z. G., & Luckhaus, C.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-11-29
- Volume
- 17
- Issue
- 05
- Pages
- 823-832
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2137172145
- Cited by
- 46
- References
- 7
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1017/s1461145713001417
- The paper
- Laoutidis, Z. G., & Luckhaus, C. (2014). 5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145713001417
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.